Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Biocon Limited
BIOCONBiocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India. Address: 20th KM Hosur Road, Bengaluru, India, 560100
Analytics
Objectif de Cours de WallStreet
27 962.48 INRRatio C/B
26.7304Rendement du dividende
0.15 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés BIOCON
Analyse des dividendes BIOCON
Croissance des dividendes sur 5 ans
200 %Croissance continue
1 annéeRatio de distribution Moyenne sur 5 ans
18 %Historique des dividendes BIOCON
Valorisation des titres BIOCON
financières BIOCON
Résultats | 2019 | Dynamique |